Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Xeomin as a Prophylactic Therapy for Migraine in Patients With Traumatic Brain Injuries (TBIs) Versus Anomalous Health Incidents (AHIs)

NCT07267819 is registered in ClinicalTrials.gov with Uniformed Services University of the Health Sciences as lead sponsor.

NCT NCT07267819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Xeomin as a Prophylactic Therapy for Migraine in Patients With Traumatic Brain Injuries (TBIs) Versus Anomalous Health Incidents (AHIs)
Lead sponsor
Uniformed Services University of the Health Sciences
Phase
Observational
Overall status
Recruiting
Start date
August 5, 2025
Completion date
June 6, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anomalous health incidents, migraine, traumatic brain injury